CAS 314027-66-2

1H-Benzimidazole, 2,2'-[1-[(2-methoxyphenyl)methyl]-1,2-ethanediyl]bis- (9CI)

Description:

1H-Benzimidazole, 2,2'-[1-[(2-methoxyphenyl)methyl]-1,2-ethanediyl]bis- is a chemical compound characterized by its complex structure, which includes a benzimidazole core and a substituted ethylene bridge. The presence of the methoxyphenyl group contributes to its potential for various biological activities, making it of interest in medicinal chemistry. This compound typically exhibits properties such as moderate solubility in organic solvents and limited solubility in water, which is common for many benzimidazole derivatives. Its molecular structure suggests potential interactions with biological targets, possibly influencing enzyme activity or receptor binding. The compound may also display fluorescence properties, which can be useful in analytical applications. As with many organic compounds, it is essential to handle it with care, considering safety protocols due to potential toxicity or reactivity. Overall, this compound's unique structural features and potential applications make it a subject of interest in research and development within the fields of pharmaceuticals and organic chemistry.

Formula: C₂₄H₂₂N₄O

Synonyms:

• 1H-Benzimidazole, 2,2'-[1-[(2-methoxyphenyl)methyl]-1,2-ethanediyl]bis- (9CI)

DBMB

CAS: 314027-66-2

DBMB is a spleen tyrosine kinase (Syk) inhibitor that significantly suppresses Syk enzyme activity. It possesses anti-inflammatory properties by inhibiting NF-κB signaling, thereby reducing the production of inflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2). DBMB can be utilized in research on inflammatory diseases.

Formula: C₂₄H₂₂N₄O

Color and Shape: Solid

Molecular weight: 382.458

Ref: TM-T204568